Stock ROSGQ ROSETTA GENOMICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Rosetta Genomics Ltd.

Equities

ROSGQ

IL0011026494

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 08:04:46 12/02/2024 pm IST 		5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for Rosetta Genomics Ltd. -.--% -.--%
2018 Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd.. CI
2018 Rosetta Genomics Ltd.(NasdaqCM:ROSG) dropped from NASDAQ Composite Index CI

Business Summary

Rosetta Genomics Ltd. is an Israel-based company engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA), and protein biomarkers, and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH). The Company is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal. The Company's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The Company focuses on developing a diagnostic assay, RosettaGX Reveal V2. It is also focusing on developing Bladder cancer risk stratification.

Number of employees: 86

Sales per Business

USD in Million2015Weight2016Weight Delta
MicroRNA-based Molecular Diagnostic
100.0 %
8 100.0 % 9 100.0 % +11.68%

Sales per region

USD in Million2015Weight2016Weight Delta
Israel and United States
100.0 %
8 100.0 % 9 100.0 % +11.68%

Managers

Managers TitleAgeSince
Ron Kalfus DFI
 Director of Finance/CFO 50 24/12/24
Nicole Massoll PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
David Sidransky BRD
 Director/Board Member 64 22/09/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,929,860 5,929,860 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
Philadelphia Investment Partners LLC
0.0703 %
4,167 0.0703 % - $
Akros Capital LLC
0.003541 %
210 0.003541 % - $
Banque BPP SA
0.003508 %
208 0.003508 % - $

Company contact information

Rosetta Genomics Ltd.

10 Plaut Street Science Park

76706, Rehovot

+972 73 222 0700

address Rosetta Genomics Ltd.(ROSGQ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ROSETTA GENOMICS LTD. Stock Rosetta Genomics Ltd.
-.--% 592
MODERNA, INC. Stock Moderna, Inc.
+26.32% 42.68B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.63% 42.4B
LONZA GROUP AG Stock Lonza Group AG
+45.32% 40.04B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+7.14% 24.94B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.82% 18.96B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.44% 12.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.46% 11.95B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-1.13% 11.55B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ROSGQ Stock
  4. Company Rosetta Genomics Ltd.